Main > > >UROLOGY.

---

Benign Prostate Hyperplasia (BPH).
TREAT.: Embolization. Pressure-Directed Arterial Embolization.
Balloon Occlusion Microcatheters.
EU Clearance Date: 2018. 08.31.
USA Clearance Date: 2018. 06.28.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 10.25.




Benign Prostate Hyperplasia (BPH).
TREAT.: Resectoscope. Single Use.
TURP Procedure
USA Clearance Date: ?
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.21.




Erectile DysFunction. Treat.: Sildena
fil Capsule. Generics. (S)
AU Approval Date: 2018. 08.06.
(*) Company; Patent APP. & TradeMark
Available on Request.
UpDate: 2018. 08.07.




Female SUI. Treat.: Transcutaneous Elec- trical Stimulation Continence Device.
Women Health.
USA Approval Date: 2018. 11.12.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 04.04.




Hyperactive Bladder. Symptoms Reduction:
Natural Health Product (NHP).
CA Launch Date: 2018. 04.09.
(*) Company : Acerus Pharmaceuticals
www.aceruspharma.com
TradeMark: UriVarx
UpDate: 2018. 04.10.




Male Urinary InContinence (UI)>ReUsable
& Washable Barrier.
CA; EU & USA>Approved.
(*) Company; TradeMark; USA Patent APP.;
& Web-Site Available on Request.
UpDate: 2020. 01.06.




NephroLithiasis. Treat.: Holmium Laser Lithotripsy.
Launch Date: 2017. 05.12.
(*) Company; TradeMark & Web-Site Avai-
lable on Request.
UpDate: 2018. 10.19.




Neurogenic Detrusor Overactivity (NDO)
in Pediatrics
USA Approval Date: 2021. 03.26.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 03.30.




OverActive Bladder (OAB). TREAT.:
Mirabegron
CA & USA Approval Date: 2013. 04.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 03.30.




OverActive Bladder (OAB). TREAT.: rechargeable Sacral NeuroModulation (SNM) System.
1st Generation (1G): Recharge Device for
1 Hour Every 2
Weeks.
2nd Generation (2G): Recharge Device for
1 Hour Once a Month
External Trial System>
>Trial the therapy and assess symptom
improvement prior to having the patient
undergo the full implant procedure.
>CA Approval Date: 2018. 11.07.
>EU Approval Date: 2018. 07.09.
AU 1G Approval : 2018. 01.08.
CA 1G Approval : 2016. 12.
EU 1G Approval : 2016. 06.
USA 1G 1st Patient Treat.: 2019. 11.01.
USA 1G Approval : 2019. 09.09.
USA 2G Approval : 2020. 04.14.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 05.04.




>UROLOGY.'s products
This section has no products